drugset / Trial / NCT00443521

Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

NCT00443521

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate intravitreal injection of triamcinolone acetonide after laser panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.

Timeline

Start
2005-03
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 4 mg Intravitreal

Indications